Skip to main content
HONZ PHARMACEUTICAL CO., LTD. logo

HONZ PHARMACEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 300086 ISIN · CNE100000QM6 LEI · 300300SA7ZULJ816T861 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,011 across all filing types
Latest filing 2024-08-21 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300086

About HONZ PHARMACEUTICAL CO., LTD.

https://www.honz.com.cn

HONZ Pharmaceutical Co., Ltd. focuses on the research, development, manufacturing, and marketing of pharmaceutical products, with a specialized emphasis on pediatric healthcare. The company provides a diverse range of medications specifically formulated for children, including antipyretics, analgesics, respiratory treatments, and anti-infective agents. It utilizes advanced drug delivery systems and taste-masking technologies to enhance patient compliance and therapeutic efficacy. In addition to its pediatric portfolio, the organization produces various chemical drugs and traditional Chinese medicine preparations. The company maintains multiple production bases and research centers dedicated to advancing clinical solutions and ensuring high standards of product quality across its therapeutic categories.

Recent filings

Filing Released Lang Actions
关于公司成为海关AEO高级认证企业的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from 康芝药业股份有限公司 about the company receiving the AEO (Authorized Economic Operator) Advanced Certification from the Haikou Customs. It explains the certification, its benefits, and the impact on the company's operations. The document is short (1115 characters), contains no financial data or detailed financial reports, and is clearly an announcement of a certification event rather than a financial or regulatory report. It does not fit into categories like Annual Report, Interim Report, or Regulatory Filings related to financial disclosures. It is a general regulatory announcement about a certification status, which fits best under Regulatory Filings (RNS) as a miscellaneous regulatory announcement that does not fit other specific categories.
2024-08-21 Chinese
第六届董事会第十二次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of a board meeting resolution regarding the appointment of a new Chief Financial Officer (CFO). It includes details about the meeting date, voting results, and the biography of the appointed individual. There are no financial statements, earnings data, or detailed financial analysis present. The document is focused on management changes at the board or senior management level. Therefore, it fits the category of Board/Management Information (MANG). The document length is short (1312 characters), and it is not an announcement of a report publication or a certification. Hence, the classification is MANG with high confidence.
2024-07-24 Chinese
关于聘任公司财务总监的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of a new Chief Financial Officer (CFO) for the company 康芝药业股份有限公司. It includes details about the board meeting where the appointment was approved, the qualifications of the appointed individual, and compliance with relevant laws and regulations. There are no financial statements, earnings data, or detailed financial analysis present. The document is a formal announcement of a management change, specifically the hiring of a senior executive. Therefore, it fits the category of Board/Management Information (MANG). The document length is short (1184 characters), consistent with an announcement rather than a full report.
2024-07-24 Chinese
关于公司控股股东部分股份解除质押的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement regarding the release of pledged shares by the controlling shareholder of the company. It details the number of shares released from pledge, the total pledged shares, and related shareholder information. There are no financial statements, earnings data, or management discussion. The document is short (1989 characters) and serves as a disclosure of share pledge status, which is a capital structure related update. This fits the category of Capital/Financing Update (CAP).
2024-07-04 Chinese
北京中伦（海口）律师事务所出具的关于康芝药业股份有限公司2023年度股东大会的法律意见书
AGM Information Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the 2023 Annual General Meeting (AGM) of 康芝药业股份有限公司. It details the procedures of convening and holding the AGM, the qualifications of attendees, the agenda items, voting procedures, and the voting results. The document includes legal opinions on the validity and compliance of the AGM process and results with relevant laws and company regulations. It does not contain the actual annual report or financial statements but focuses on the AGM process and voting outcomes. Therefore, this document is best classified as AGM Information (AGM-R), which covers presentations and materials shared during the AGM, including legal opinions on the meeting.
2024-06-28 Chinese
2023年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2023 Annual General Meeting (AGM) of 康芝药业股份有限公司. It includes information about the meeting date, voting methods, attendance, and the voting results for various proposals such as the 2023 annual report, financial statements, profit distribution plan, amendments to company bylaws, appointment of auditors, and board nominations. The document also mentions legal opinions confirming the validity of the meeting and voting process. The content is focused on the official results and decisions made at the AGM rather than the full annual report or financial statements themselves. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length (8638 characters) and detailed voting results support this classification rather than a brief announcement or a full report.
2024-06-28 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.